JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $571,000 | +17.7% | 12,492 | +15.6% | 0.00% | +33.3% |
| Q3 2017 | $485,000 | +50.2% | 10,810 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $323,000 | +34.6% | 10,810 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $240,000 | +17.6% | 10,799 | -0.2% | 0.00% | 0.0% |
| Q4 2016 | $204,000 | -37.2% | 10,824 | -0.1% | 0.00% | -33.3% |
| Q3 2016 | $325,000 | -21.9% | 10,831 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $416,000 | +18.9% | 10,824 | +17.8% | 0.00% | 0.0% |
| Q1 2016 | $350,000 | +1958.8% | 9,191 | +2299.7% | 0.00% | – |
| Q4 2015 | $17,000 | +13.3% | 383 | +0.8% | 0.00% | – |
| Q3 2015 | $15,000 | -25.0% | 380 | -1.0% | 0.00% | – |
| Q2 2015 | $20,000 | – | 384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |